<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01630317</url>
  </required_header>
  <id_info>
    <org_study_id>ULISES</org_study_id>
    <nct_id>NCT01630317</nct_id>
  </id_info>
  <brief_title>Slow Continuous Ultrafiltration Using Central vs Peripheral Line: Feasibility of Implementation, Safety and Efficacy in Acute Heart Failure Syndromes.</brief_title>
  <official_title>Slow Continuous Ultrafiltration Using Central vs Peripheral Line: Feasibility of Implementation, Safety and Efficacy in Acute Heart Failure Syndromes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Parc de Salut Mar</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Parc de Salut Mar</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Slow continuous ultrafiltration using central vs peripheral line: feasibility of
      implementation, safety and efficacy in acute heart failure syndromes.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>November 2011</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy</measure>
    <time_frame>48 hours after initiation of scuf therapy</time_frame>
    <description>Compare patient global improvement 48 hours after initiation of scuf therapy in a group of patients with the same features treated by peripheral access against a group of patients with the same features treated by central access. This outcome will be measured by patient global assessment</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Security</measure>
    <time_frame>5th day of the study</time_frame>
    <description>Compare complications in acute heart failure patients treated with scuf, in a group treated by peripheral line vs central line. This outcome will be assessed by a safety score at the AE at the 5th day of the study. ( 0 : no AE and 79 understood as the worse punctuation for the AE). Every AE has a punctuation related to the seriousness.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">33</enrollment>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>Peripheral acces</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Central access</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Peripheral line</intervention_name>
    <description>Ultrafiltration therapy though peripheral line, two peripheral venous catheter will be placed in the arms.</description>
    <arm_group_label>Peripheral acces</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Central line vein</intervention_name>
    <description>Ultrafiltration therapy through central line, a central venous catheter will be placed in internal jugular or femoral vein.</description>
    <arm_group_label>Central access</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  ≥ 18 years

          -  Patients hospitalized with primary diagnosis of acute heart failure defined as ≥ 2 of
             the following criteria:

          -  Peripheral or sacral edema

          -  Jugular venous distension or venous central pressure &gt; 10 mmHg

          -  Hepatomegaly or ascites

          -  Pulmonary edema or pleural effusion on x-ray or pulmonary wedge pressure or
             end-diastolic pressure &gt; 20 mmHg.

          -  High pro-BNP

          -  Randomization during first 24 hours

          -  Serum creatinine levels &lt; 3mg/dL, and K &lt; 6 mmol/L

          -  The patient should be able to communicate with research staff and meet with study
             procedures.

          -  The patient will signed informed consent.

        Exclusion Criteria:

          -  Diagnosis of severe aortic stenosis or severe obstruction to the LVOT, tamponade,
             cardiac hypertrophic or restrictive cardiomyopathy.

          -  Impossibility of venous catheterization

          -  Acute coronary syndrome

          -  Creatinine greater than 3.0 or K greater than 6 mmol/L.

          -  Systolic blood pressure less than or equal to 100 mmHg

          -  Hematocrit greater than 45%

          -  Prior administration of IV vasoactive drugs in the emergency room (ER)

          -  Clinical instability requiring pressors during hospitalization

          -  Sepsis

          -  On or requires renal dialysis.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Cardiology Service, Hospital del Mar. Passeig Maritim 25-29,</name>
      <address>
        <city>Barcelona</city>
        <zip>08003</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 21, 2012</study_first_submitted>
  <study_first_submitted_qc>June 26, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 28, 2012</study_first_posted>
  <last_update_submitted>April 25, 2016</last_update_submitted>
  <last_update_submitted_qc>April 25, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 26, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Parc de Salut Mar</investigator_affiliation>
    <investigator_full_name>Nuria Ribas</investigator_full_name>
    <investigator_title>Nuria Ribas</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

